On Demand : Turning Complexity into Custom Epidemiology
Speakers
Precision medicine, orphan designations, and increasingly specific trial criteria have exploded the permutations of “the right patient” and turned the once-simple question — “How many patients?” — into a moving target.
Off-the-shelf epidemiology still answers around 80% of questions. But for the critical 20% — those involving narrow populations, rare diseases, or complex treatment pathways — answers are often too coarse, missing entirely, or fragmented across teams using inconsistent assumptions. If you’re working on a therapy with a narrowly defined patient segment, struggling to align internal teams on the true opportunity, or need epidemiology that reflects your product, not just the market, this session is for you.
In this webinar, you’ll learn how pharma teams could move beyond static data and fragmented models through a holistic blend of syndicated reports, tailored epidemiology, and flexible consulting support. We’ll show how to align stakeholders around a unified version of the truth and deliver decision-grade insights that feed forecasting, pricing, access, BD&L, and valuation.
We’ll also provide a glimpse into how we’re helping clients leave Excel chaos behind, with scalable, scenario-driven platforms that enable cross-functional collaboration, version control, and faster alignment across global and local teams.
